Put Yourself In The CEO’s Shoes: Audience Makes Drug Pricing And Investment Decisions At EHFG

A pricing simulation exercise at the recent EHFG conference gave delegates an idea of the multiple factors that have to be taken into account when setting the price of a new drug for a rare disease – and deciding which candidate molecules are worth investing in.